Global cognitive scores do not predict outcome after subthalamic nucleus deep brain stimulation

Area of Science:

• Neurosurgery
• Neurology
• Cognitive Science

Background:

• Dementia is a contraindication for deep brain stimulation (DBS) in Parkinson's disease (PD).
• Previous studies suggested borderline cognitive function, assessed by the Mattis Dementia Rating Scale (MDRS), negatively impacts quality of life (QoL) post-STN DBS.
• This study investigates the predictive value of preoperative cognitive function on QoL outcomes after DBS.

Purpose of the Study:

• To replicate and extend findings on the association between cognitive function and QoL after STN DBS.
• To evaluate the utility of a common cognitive screening tool in predicting outcomes in a broader patient population.

Main Methods:

• A larger cohort of Parkinson's disease patients undergoing STN DBS was studied.
• Preoperative global cognitive performance was assessed using a standard screening measure.
• Quality of life and medical outcomes were evaluated post-surgery.

Main Results:

• Performance on the cognitive screening measure was not associated with QoL outcomes.
• Medical outcomes also showed no correlation with scores on the screening tool.
• These findings held true even for scores significantly below the dementia cutoff.

Conclusions:

• The studied cognitive screening measure demonstrates insufficient sensitivity for predicting QoL benefits from STN DBS.
• Relying solely on this screening tool may not accurately identify patients who will benefit from DBS.
• Further research may be needed to identify more sensitive cognitive markers for DBS candidacy.